| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |